Table 3.
Most cited basic science articles on ependymoma
| Basic science rank (TC) | Overall rank (TC) | Overall rank (CY) | Title | Authors (first/last) | Journal title | Publication year | Total citations | Average citations per year | Country |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 3 | Radial glia cells are candidate stem cells of ependymoma | Taylor MD, Gilbertson RJ | Cancer Cell | 2005 | 551 | 34.44 | USA |
| 2 | 3 | 1 | Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups | Pajtler KW, Pfister SM | Cancer Cell | 2015 | 321 | 53.5 | Germany |
| 3 | 5 | 2 | C11orf95-RELA fusions drive oncogenic Nf-kappa B signalling in ependymoma | Parker M, Gilbertson RJ | Nature | 2014 | 272 | 38.86 | USA |
| 4 | 7 | 4 | Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma | Witt H, Pfister SM | Cancer Cell | 2011 | 244 | 24.4 | Germany |
| 5 | 9 | 7 | Cross-species genomics matches driver mutations and cell compartments to model ependymoma | Johnson RA, Gilbertson RJ | Nature | 2010 | 219 | 19.91 | USA |
| 6 | 10 | 25 | Natural simian-virus-40 strains are present in human choroid-plexus and ependymoma tumors | Lednicky JA, Butel JS | Virology | 1995 | 206 | 7.92 | USA |
| 7 | 14 | 14 | Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics | Modena P, Sozzi G | Journal of Clinical Oncology | 2006 | 160 | 10.67 | Italy |
| 8 | 15 | 15 | Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma | Mendrzyk F, Lichter P | Clinical Cancer Research | 2006 | 156 | 10.4 | Germany |
| 9 | 16 | 29 | Molecular genetic analysis of ependymal tumors: Nf2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas | Ebert C, Von Deimling A | American Journal of Pathology | 1999 | 154 | 7 | USA |
| 10 | 18 | 34 | Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma | Chan AS, Chung LP | American Journal of Surgical Pathology | 1998 | 151 | 6.57 | Hong Kong |
| 11 | 31 | 35 | Erbb receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease | Gilbertson RJ Ellison DW | Clinical Cancer Research | 2002 | 123 | 6.47 | USA |
| 12 | 35 | 13 | Molecular staging of intracranial ependymoma in children and adults | Korshunov A, Pfister SM | Journal of Clinical Oncology | 2010 | 119 | 10.82 | Germany |
| 13 | 44 | 51 | Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups | Hirose Y, Feuerstein BG | American Journal of Pathology | 2001 | 98 | 4.9 | USA |
| 14 | 57 | 24 | Identification of microRNAs as potential prognostic markers in ependymoma | Costa FF Soares MB | Plos One | 2011 | 80 | 8 | USA |
| 15 | 63 | 20 | A prognostic gene expression signature in infratentorial ependymoma | Wani K, Aldape K | Acta Neuropathologica | 2012 | 78 | 8.67 | USA |
| 16 | 74 | 28 | An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma | Atkinson JM, Gilbertson RJ | Cancer Cell | 2011 | 71 | 7.1 | USA |
| 17 | 78 | 49 | Differential expression and prognostic significance of sox genes in pediatric medulloblastoma and ependymoma identified by microarray analysis | De Bont JM, Pieters R | Neuro-Oncology | 2008 | 69 | 5.31 | Netherlands |
| 18 | 80 | 54 | Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival | Lukashova-Von Zangen I, Roggendorf W | Acta Neuropathologica | 2007 | 66 | 4.71 | Germany |
| 19 | 85 | 78 | Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma | Reardon DA, Look AT | Genes Chromosomes & Cancer | 1999 | 65 | 2.95 | USA |